COCP READ THE FULL COCP RESEARCH REPORT Business Update Norovirus Challenge Study to Commence in 4Q25 Cocrystal Pharma, Inc. ...

“The absence of any approved norovirus treatments or vaccines creates a substantial market opportunity for Cocrystal,” said James Martin, Cocrystal's CFO and co-CEO. “ With 685 million global cases ...

All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well toleratedCompany expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this ...

Get the latest Cocrystal Pharma Inc (8CC.SG) stock news and headlines to help you in your trading and investment decisions.

All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well toleratedCompany expects to initiate Phase 1b study with CDI-988 in norovirus-infected healthy subjects later this ...

Preparations are underway for a Phase 1b norovirus challenge study to evaluate our potent, oral antiviral candidate CDI-988 as a prophylaxis and ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Musclemecca.com, a premier online destination for bodybuilding and fitness enthusiasts, has announced the release of a ...

German biotechnology company Coriolis Pharma has chosen Morrisville for its first U.S. facility and headquarters, becoming the inaugural tenant of the Spark Axis Building. The company plans a $10 ...

With an uptick in licensing deals and promising data emerging from China-based biopharmas, especially in oncology, it’s clear the country is poised to play a major r | In this episode of "The ...

President Trump Is Targeting Big Pharma With Tariffs Pharma stocks like Novo Nordisk and Pfizer have dropped amid trade war risks.

OU result 2025: Osmania University has declared the 2025 results for various undergraduate courses, including B.Sc (Hons), B.Com, BA, BBA, and Pharma-D. The results for the June 2025 semester ...